Kash Patel Becomes the Focus of Media Analysis They Consistently Get Wrong
How America Has Destroyed Its Democracy, Part Two: The Aristocracy of Merit
Three Congressional Missteps on Healthcare
Today’s Qualifications to Be President of the U.S.
Climate Alarmists Howl After EPA Rescinds ‘Endangerment Finding’
Ukraine's Bureaucrats Are Finishing What China Started
Rising Federal Debt: Why Strategic Planning Matters More Than Ever for High-Net-Worth Fami...
Classroom Political Activism Shifts a Teacher’s Role from Educator to Indoctrinator
As America Celebrates 250, We Must Help Iran Celebrate Another 2,500
Guatemalan Citizen Admits Using Stolen Identity to Obtain Custody of Teen Migrant
Oregon-Based Utility PacifiCorp Settles for $575M Over Six Devastating Wildfires
Armed Man Rammed Substation Near Las Vegas in Apparent Terror Plot Before Committing...
DOJ Moves to Strip U.S. Citizenship From Former North Miami Mayor Over Immigration...
DOJ Probes Three Michigan School Districts That Allegedly Teach Gender Ideology
5th Circuit Vacates Ruling That Blocked Louisiana's Mandate to Display 10 Commandments in...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos